Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC4R | P32245 | 7/20 | 0.55 |
| ▸ | MC1R | Q01726 | 7/20 | 0.55 |
| ▸ | TACR2 | P21452 | 3/20 | 0.46 |
| ▸ | CCKBR | P32239 | 6/20 | 0.44 |
| ▸ | NPY4R | P50391 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20362979 | 1.00 | MC4R (0.55) | MC4RMC1RTACR2CCKBRNPY4R | |
| SCHEMBL21392332 | 1.00 | MC4R (0.55) | MC4RMC1RTACR2CCKBRNPY4R | |
| SCHEMBL21392338 | 0.93 | MC4R (0.57) | MC4RMC1R | |
| SCHEMBL20362958 | 0.93 | MC4R (0.57) | MC4RMC1R | |
| SCHEMBL21392264 | 0.93 | MC4R (0.57) | MC4RMC1R | |
| SCHEMBL20206244 | 0.93 | MC4R (0.57) | MC4RMC1R | |
| SCHEMBL20206296 | 0.92 | MC1R (0.56) | MC4RMC1RNPY4R | |
| SCHEMBL20206276 | 0.92 | MC1R (0.53) | MC4RMC1RTACR2CCKBRNPY4R | |
| SCHEMBL20206176 | 0.92 | MC1R (0.53) | MC4RMC1RTACR2CCKBRNPY4R | |
| SCHEMBL20206282 | 0.91 | MC4R (0.55) | MC4RMC1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10017539-B2 | Melanocortin-1 receptor-specific cyclic hexapeptides | PALATIN TECHNOLOGIES, INC. (US) | 2018-07-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10017539-B2 | Melanocortin-1 receptor-specific cyclic hexapeptides | MC1R, MC3R, MC5R | MC4R 4/4885MC1R 1/4885TACR2 229/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.